{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:29:17Z","timestamp":1794022157236,"version":"4.8.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"KLE Academy of Higher Education and Research (KAHER), Belagavi, Karnataka, India, under the KAHER Major Research Grants scheme","award":["KAHER\/RD\/23-24\/D-23022401"],"award-info":[{"award-number":["KAHER\/RD\/23-24\/D-23022401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00645-w","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T07:10:22Z","timestamp":1754982622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Computational and experimental repositioning of quinoline analogues as KSP inhibitors: insights from free energy landscape and PCA analysis"],"prefix":"10.1007","volume":"39","author":[{"given":"Shankar G.","family":"Alegaon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriram D.","family":"Ranade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Gharge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini S.","family":"Kavalapure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatasubramanian","family":"Ulaganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"2","key":"645_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bcp.13126","volume":"83","author":"D Bates","year":"2017","unstructured":"Bates D, Eastman A (2017) Microtubule destabilising agents: far more than just antimitotic anticancer drugs. Br J Clin Pharmacol 83(2):255\u2013268. https:\/\/doi.org\/10.1111\/bcp.13126","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"645_CR2","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3390\/cancers16112014","volume":"16","author":"JP Silva","year":"2024","unstructured":"Silva JP, Pinto B, Monteiro L, Silva PM, Bousbaa H (2024) Coupling Kinesin spindle protein and aurora b inhibition with apoptosis induction enhances oral cancer cell killing. Cancers 16(11):2014. https:\/\/doi.org\/10.3390\/cancers16112014","journal-title":"Cancers"},{"key":"645_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2147\/DDDT.S74062","volume":"9","author":"YH Ding","year":"2015","unstructured":"Ding YH, Zhou ZW, Ha CF, Zhang XY, Pan ST, He ZX, Edelman JL, Wang D, Yang YX, Zhang X, Duan W (2015) Alisertib, an Aurora kinase a inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells. Drug Des, Dev Ther 9:425\u2013464. https:\/\/doi.org\/10.2147\/DDDT.S74062","journal-title":"Drug Des, Dev Ther"},{"issue":"1","key":"645_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.gene.2013.08.004","volume":"531","author":"EJ Wojcik","year":"2013","unstructured":"Wojcik EJ, Buckley RS, Richard J, Liu L, Huckaba TM, Kim S (2013) Kinesin-5: cross-bridging mechanism to targeted clinical therapy. Gene 531(1):133\u2013149. https:\/\/doi.org\/10.1016\/j.gene.2013.08.004","journal-title":"Gene"},{"issue":"5","key":"645_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature03503","volume":"435","author":"LC Kapitein","year":"2005","unstructured":"Kapitein LC, Peterman EJ, Kwok BH, Kim JH, Kapoor TM, Schmidt CF (2005) The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks. Nature 435(5):114\u2013118. https:\/\/doi.org\/10.1038\/nature03503","journal-title":"Nature"},{"issue":"10","key":"645_CR6","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2174\/092986711795328382","volume":"18","author":"R Solomon","year":"2011","unstructured":"Solomon R, V, Lee H (2011) Quinoline as a privileged scaffold in cancer drug discovery. Current Med Chem 18(10):1488\u20131508. https:\/\/doi.org\/10.2174\/092986711795328382","journal-title":"Current Med Chem"},{"issue":"15","key":"645_CR7","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2174\/1381612826666201006125644","volume":"27","author":"AN Da Gama","year":"2021","unstructured":"Da Gama AN, Soeiro MN (2021) Quinoline-based compounds as key candidates to tackle drug discovery programs of microbicidal agents. Curr Pharm Des 27(15):1757\u20131762. https:\/\/doi.org\/10.2174\/1381612826666201006125644","journal-title":"Curr Pharm Des"},{"issue":"8","key":"645_CR8","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1016\/j.arabjc.2016.10.009","volume":"12","author":"S Jain","year":"2019","unstructured":"Jain S, Chandra V, Jain PK, Pathak K, Pathak D, Vaidya A (2019) Comprehensive review on current developments of quinoline-based anticancer agents. Arab J Chem 12(8):4920\u20134946. https:\/\/doi.org\/10.1016\/j.arabjc.2016.10.009","journal-title":"Arab J Chem"},{"issue":"245","key":"645_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114889","volume":"5","author":"RA Kardile","year":"2023","unstructured":"Kardile RA, Sarkate AP, Lokwani DK, Tiwari SV, Azad R, Thopate SR (2023) Design, synthesis, and biological evaluation of novel quinoline derivatives as small-molecule mutant EGFR inhibitors targeting resistance in NSCLC: in vitro screening and ADME predictions. Eur J Med Chem 5(245):114889. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114889","journal-title":"Eur J Med Chem"},{"issue":"22","key":"645_CR10","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1016\/j.bmcl.2010.09.014","volume":"20","author":"Y Yang","year":"2010","unstructured":"Yang Y, Shi L, Zhou Y, Li HQ, Zhu ZW, Zhu HL (2010) Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors. Bioorg Med Chem Lett 20(22):6653\u20136656. https:\/\/doi.org\/10.1016\/j.bmcl.2010.09.014","journal-title":"Bioorg Med Chem Lett"},{"issue":"193","key":"645_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112241","volume":"1","author":"X Nan","year":"2020","unstructured":"Nan X, Li HJ, Fang SB, Li QY, Wu YC (2020) Structure-based discovery of novel 4-(2-fluorophenoxy) quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions. Eur J Med Chem 1(193):112241. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112241","journal-title":"Eur J Med Chem"},{"issue":"116","key":"645_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105381","volume":"1","author":"RS Kavalapure","year":"2021","unstructured":"Kavalapure RS, Alegaon SG, Venkatasubramanian U, Priya AS, Ranade SD, Khanal P, Mishra S, Patil D, Salve PS, Jalalpure SS (2021) Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents. Bioorg Chem 1(116):105381. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105381","journal-title":"Bioorg Chem"},{"issue":"105","key":"645_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2023.107881","volume":"1","author":"SD Ranade","year":"2023","unstructured":"Ranade SD, Alegaon SG, Venkatasubramanian U, Priya AS, Kavalapure RS, Chand J, Jalalpure SS, Vinod D (2023) Design, synthesis, molecular dynamics simulation, MM\/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids. Comput Biol Chem 1(105):107881. https:\/\/doi.org\/10.1016\/j.compbiolchem.2023.107881","journal-title":"Comput Biol Chem"},{"issue":"18","key":"645_CR14","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1016\/j.bmc.2011.07.029","volume":"19","author":"C Jiang","year":"2011","unstructured":"Jiang C, Yang L, Wu WT, Guo QL, You QD (2011) De novo design, synthesis and biological evaluation of 1, 4-dihydroquinolin-4-ones and 1, 2, 3, 4-tetrahydroquinazolin-4-ones as potent kinesin spindle protein (KSP) inhibitors. Bioorg Med Chem 19(18):5612\u20135627. https:\/\/doi.org\/10.1016\/j.bmc.2011.07.029","journal-title":"Bioorg Med Chem"},{"key":"645_CR15","doi-asserted-by":"publisher","first-page":"11160","DOI":"10.18632\/oncotarget.14466","volume":"8","author":"P Wolter","year":"2017","unstructured":"Wolter P, Hanselmann S, Pattschull G, Schruf E, Gaubatz S (2017) Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy. Oncotarget 8:11160. https:\/\/doi.org\/10.18632\/oncotarget.14466","journal-title":"Oncotarget"},{"issue":"13","key":"645_CR16","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1021\/ja310377d","volume":"135","author":"V Ulaganathan","year":"2013","unstructured":"Ulaganathan V, Talapatra SK, Rath O, Pannifer A, Hackney DD, Kozielski F (2013) Structural insights into a unique inhibitor binding pocket in kinesin spindle protein. J Am Chem Soc 135(13):2263\u20132272. https:\/\/doi.org\/10.1021\/ja310377d","journal-title":"J Am Chem Soc"},{"issue":"16","key":"645_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(16):55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"issue":"73","key":"645_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.compbiolchem.2018.02.008","volume":"1","author":"T Ban","year":"2018","unstructured":"Ban T, Ohue M, Akiyama Y (2018) Multiple grid arrangement improves ligand docking with unknown binding sites: application to the inverse docking problem. Comput Biol Chem 1(73):139\u2013146. https:\/\/doi.org\/10.1016\/j.compbiolchem.2018.02.008","journal-title":"Comput Biol Chem"},{"key":"645_CR19","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"645_CR20","doi-asserted-by":"publisher","unstructured":"Bowers, K. J.; Chow, E.; Xu, H.; Dror, R. O.; Eastwood, M. P.; Gregersen, B. A.; Klepeis, J. L.; Kolossvary, I.; Moraes, M. A.; Sacerdoti, F. D.; Salmon, J. K.; Shan, Y.; Shaw, D. E., \u201cScalable algorithms for molecular dynamics simulations on commodity clusters\u201d, Proceedings of the ACM\/IEEE conference on supercomputing (SC06), Tampa, Florida, 2006, November 11\u201317 https:\/\/doi.org\/10.1145\/1188455.1188544.","DOI":"10.1145\/1188455.1188544"},{"issue":"11","key":"645_CR21","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1021\/acs.jcim.3c00013","volume":"63","author":"W Chen","year":"2023","unstructured":"Chen W, Cui D, Jerome SV, Michino M, Lenselink EB, Huggins DJ, Beautrait A, Vendome J, Abel R, Friesner RA, Wang L (2023) Enhancing hit discovery in virtual screening through absolute protein\u2013ligand binding free-energy calculations. J Chem Inf Model 63(11):3171\u20133185. https:\/\/doi.org\/10.1021\/acs.jcim.3c00013","journal-title":"J Chem Inf Model"},{"issue":"16","key":"645_CR22","doi-asserted-by":"publisher","first-page":"1480732","DOI":"10.3389\/fphar.2025.1480732","volume":"18","author":"VS Patil","year":"2025","unstructured":"Patil VS, Patil CR, Patel HM, Kumar A (2025) Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches. Front Pharmacol 18(16):1480732. https:\/\/doi.org\/10.3389\/fphar.2025.1480732","journal-title":"Front Pharmacol"},{"issue":"5","key":"645_CR23","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1021\/acs.jcim.1c00338","volume":"61","author":"EN Bingol","year":"2021","unstructured":"Bingol EN, Sercinoglu O, Ozbek P (2021) Unraveling the allosteric communication mechanisms in T-cell receptor\u2013peptide-loaded major histocompatibility complex dynamics using molecular dynamics simulations: an approach based on dynamic cross-correlation maps and residue interaction energy calculations. J Chem Inf Model 61(5):2444\u20132453. https:\/\/doi.org\/10.1021\/acs.jcim.1c00338","journal-title":"J Chem Inf Model"},{"issue":"46","key":"645_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jmgm.2013.09.005","volume":"1","author":"C Mulakala","year":"2013","unstructured":"Mulakala C, Viswanadhan VN (2013) Could MM-GBSA be accurate enough for the calculation of absolute protein\/ligand binding free energies? J Mol Graph Model 1(46):41\u201351. https:\/\/doi.org\/10.1016\/j.jmgm.2013.09.005","journal-title":"J Mol Graph Model"},{"issue":"9","key":"645_CR25","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1039\/D4MD00344F","volume":"15","author":"SD Ranade","year":"2024","unstructured":"Ranade SD, Alegaon SG, Khatib NA, Gharge S, Kavalapure RS (2024) Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study. RSC Med Chem 15(9):3162\u20133179. https:\/\/doi.org\/10.1039\/D4MD00344F","journal-title":"RSC Med Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00645-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:56:38Z","timestamp":1762451798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00645-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00645-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}